M&A / Deals Pfizer signs licence agreement with Chai for AI drug discovery Pharmaceutical TechnologyPfizer and Chai Discovery have signed a licence deal enabling the former to incorporate Chai's AI platform into its drug discovery operations.Read full story pharminent June 5, 2026 (Last updated: June 5, 2026) Pharmaceutical Technology Pfizer and Chai Discovery have signed a licence deal enabling the former to incorporate Chai’s AI platform into its drug discovery operations. Read full story Post navigation Previous: Boan Biotech Submits BLA to FDA for Two Denosumab BiosimilarsNext: Biogen’s salanersen gains FDA breakthrough therapy designation for SMA Related Stories M&A / Deals Solstice Oncology secures $225m to drive porustobart’s development for cancer pharminent September 10, 2026 M&A / Deals UK’s Claret Capital raises 575m for European biotechs pharminent September 7, 2026 M&A / Deals GSK wagers up to $1.3B on a different kind of cancer drug pharminent September 3, 2026